AXGN Q4 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$60M+21.3% YoY

Gross Profit

$44M74.1% margin

Operating Income

-$10M-16.3% margin

Net Income

-$13M-22.0% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$222M

Total Liabilities

$93M

Stockholders' Equity

$129M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$49M	+21.3%
Gross Profit	$44M	$38M	+18.2%
Operating Income	-$10M	$2M	-584.5%
Net Income	-$13M	$450,000	-3023.6%